UVALX Performance — Victory Value Fund, Shares
Data updated: 2026-09-29
UVALX returned +13.63% year to date and +26.07% over one year to Jul 2026. Annualised returns are +16.67% over 3 years and +11.65% over 5 years. The fund beat its US Multi-Cap Value category average: $100 invested three years ago grew to $159, against $137 for the category, and to $126 over one year, against $110. Volatility over the past three years was 11.77% a year. In the 12 months to Jul 2026 the fund took in a net $19.0M, and assets reached $1.50B.
UVALX Growth of $100
What $100 invested in Victory Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Value category average over the same months.
| Period | UVALX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $126 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $159 | $137 |
| 5 years (Aug 2021 – Jul 2026) | $173 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $219 | $186 |
UVALX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.63% |
| 1 year | +26.07% |
| 3 years (annualised) | +16.67% |
| 5 years (annualised) | +11.65% |
UVALX Annual Returns
Calendar-year total returns of Victory Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +13.63% |
| 2025 | +16.19% |
| 2024 | +15.62% |
| 2023 | +13.90% |
| 2022 | −5.68% |
| 2021 | +25.89% |
| 2020 | −1.02% |
| 2019 (Aug–Dec) | +7.40% |
UVALX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.4% | +3.1% | −5.3% | +6.0% | +0.5% | +1.2% | +4.3% | — | — | — | — | — |
| 2025 | +4.5% | −0.3% | −2.8% | −2.8% | +3.1% | +3.5% | −0.4% | +4.2% | +2.0% | −0.5% | +4.0% | +0.9% |
| 2024 | +1.0% | +4.2% | +5.7% | −4.0% | +3.0% | −0.8% | +4.6% | +2.0% | +1.1% | −1.5% | +6.2% | −6.2% |
| 2023 | +5.6% | −3.1% | −0.7% | +1.7% | −3.8% | +6.6% | +3.3% | −1.6% | −2.9% | −2.6% | +5.9% | +5.6% |
| 2022 | −1.3% | −1.0% | +2.1% | −3.8% | +2.4% | −7.8% | +5.6% | −3.4% | −8.8% | +10.3% | +5.3% | −3.8% |
| 2021 | −1.0% | +5.9% | +6.8% | +4.1% | +2.6% | −1.2% | +0.8% | +1.8% | −3.7% | +4.7% | −3.7% | +7.1% |
| 2020 | −3.3% | −10.0% | −18.6% | +11.1% | +4.1% | −0.9% | +3.9% | +3.8% | −3.2% | −0.7% | +13.5% | +3.6% |
| 2019 | — | — | — | — | — | — | — | −2.8% | +3.0% | +1.6% | +3.0% | +2.4% |
UVALX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.77%
- 3-year Sharpe ratio: 1.03 (vs 4.5% risk-free rate)
- Best month: +6.23% (Nov 2024)
- Worst month: −6.21% (Dec 2024)
UVALX Fund Flows
Monthly money in and out of Victory Value Fund, from SEC Form N-PORT.
- 12-month net flow: $19.0M
- 12-month gross sales (incl. reinvestments): $193.8M
- Sales ÷ redemptions: 1.11×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.5M | $16.0M | −$11.5M |
| Jun 2026 | $6.0M | $11.4M | −$5.4M |
| May 2026 | $5.4M | $11.1M | −$5.7M |
| Apr 2026 | $5.3M | $11.1M | −$5.9M |
| Mar 2026 | $4.9M | $13.4M | −$8.6M |
| Feb 2026 | $4.7M | $17.2M | −$12.5M |
| Jan 2026 | $4.0M | $14.0M | −$10.0M |
| Dec 2025 | $139.8M | $24.6M | $115.2M |
| Nov 2025 | $6.1M | $15.3M | −$9.2M |
| Oct 2025 | $4.0M | $12.6M | −$8.6M |
| Sep 2025 | $4.5M | $17.0M | −$12.5M |
| Aug 2025 | $4.7M | $11.0M | −$6.3M |
UVALX Assets Under Management
Net assets of Victory Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.50B |
| 2026-04-30 | $1.43B |
| 2026-01-31 | $1.41B |
| 2025-10-31 | $1.34B |
| 2025-07-31 | $1.30B |
| 2025-04-30 | $1.23B |
| 2025-01-31 | $1.33B |
| 2024-10-31 | $1.31B |
| 2024-07-31 | $1.32B |
| 2024-04-30 | $1.25B |
| 2024-01-31 | $1.22B |
| 2023-10-31 | $1.10B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.